Benjamin Gill, DO
Interventional Pain Medicine · Reno, NVNPI 1356801435
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Medtronic at 34.9% of the total. 2025 is the largest year on record at $10,143, more than ten times the $18 reported in 2021. Among interventional pain medicine clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $91.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Abbott$4K
- Boston Scientific$3K
- Nevro Corp.$2K
- SPR Therapeutics, Inc$590
- Conetic Solutions, Inc.$486
- plus $4K from 26 others
What the payments were for
- Travel & lodging$9,25842%
- Food & beverage$12,03255%
- Education$7673%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 87 | $7,690 |
| Abbott | 33 | $4,243 |
| Boston Scientific | 29 | $3,312 |
| Nevro Corp. | 15 | $1,888 |
| SPR Therapeutics, Inc | 9 | $590 |
| Conetic Solutions, Inc. | 1 | $486 |
| Arthrex | 3 | $482 |
| Spinal Simplicity, LLC | 3 | $388 |
| Saluda Medical Americas, Inc. | 11 | $318 |
| Pacira Pharmaceuticals Incorporated | 2 | $300 |
| Vertos Medical, Inc. | 5 | $296 |
| MML US, Inc. | 4 | $285 |
| Curonix LLC | 2 | $258 |
| AbbVie(2 entities) | 6 | $217 |
| Ipsen Biopharmaceuticals, Inc | 3 | $188 |
| Brixton Biosciences, Inc. | 1 | $160 |
| Piramal Critical Care | 1 | $120 |
| Si-bone, Inc. | 3 | $104 |
| Pfizer | 1 | $95 |
| Stryker | 2 | $93 |
| Tersera Therapeutics LLC | 3 | $92 |
| Relievant Medsystems, Inc. | 1 | $76 |
| Globus Medical | 3 | $75 |
| Vertex | 3 | $73 |
| Bioventus LLC | 1 | $64 |
| Nalu Medical, Inc. | 1 | $34 |
| Forte Bio-pharma LLC | 2 | $31 |
| Protega Pharmaceutials Inc | 1 | $22 |
| Indivior Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Averitas Pharma Inc. | 1 | $17 |
| Biotronik NRO, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$3,243
- INTELLIS ADAPTIVESTIM$2,512
- VANTA ADAPTIVESTIM$1,525
- Senza$842
- SYNCHROMEDII$801
- Omnia$767
- Intracept$704
- GABLOFEN$481
- WaveWriter Alpha Prime 16$396
- GENERAL PAIN MANAGEMENT$392
- HA MINUTEMAN G3-R$369
- INCEPTIV$362
- Iovera$300
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$258
- ReActiv8$243
- ETERNA$229
- Evoke$191
- Neural Ice$160
- INTERSTIM$135
- mild Device Kit$134
How this compares
$22,057 in reported general payments places this provider in the 90th percentile of 32 interventional pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 14 | $14,791 |
| Nurtec OdtRimegepant Sulfate | 13 | $13,810 |
| Xtampza ErOxycodone Myristate | 25 | $13,221 |
| Fentanyl | 81 | $9,471 |
| Buprenorphine | 22 | $5,908 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 146 | $3,963 |
| Oxycodone Hcl | 195 | $3,819 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 100 | $3,079 |
| Pregabalin | 139 | $2,950 |
| Morphine Sulfate ErMorphine Sulfate | 94 | $2,558 |
| Gabapentin | 123 | $2,498 |
| Hydromorphone Hcl | 44 | $740 |
| Duloxetine Hcl | 48 | $631 |
| Morphine Sulfate | 16 | $554 |
| Tramadol Hcl | 53 | $397 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $95 | $13,81013 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $20 | $13,22125 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 32 interventional pain medicine providers in Nevada.
Other interventional pain medicine in Reno
- Ali NairiziReno$291K
- Steven BermanReno$25K
- Christopher WoolleyReno$18K
- Adam AntflickLas Vegas$26K
- Stephen GephardtLas Vegas$14K
- Jeremy LipshutzLas Vegas$13K
- Denys GoloshchapovLas Vegas$11K
- Jeffrey KatzNorth Las Vegas$7K
- Edson ErkulvrawatrLas Vegas$6K
- Alafuro OrueneLas Vegas$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.